Chau T Dang

Chau T Dang

UNVERIFIED PROFILE

Are you Chau T Dang?   Register this Author

Register author
Chau T Dang

Chau T Dang

Publications by authors named "Chau T Dang"

Are you Chau T Dang?   Register this Author

43Publications

1151Reads

32Profile Views

Assessment of Early Radiation-Induced Changes in Left Ventricular Function by Myocardial Strain Imaging After Breast Radiation Therapy.

J Am Soc Echocardiogr 2019 Apr 28;32(4):521-528. Epub 2019 Feb 28.

Cardiology Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York; Weill Cornell Medical College, New York, New York.

View Article

Download full-text PDF

Source
https://linkinghub.elsevier.com/retrieve/pii/S08947317183073
Publisher Site
http://dx.doi.org/10.1016/j.echo.2018.12.009DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6487646PMC
April 2019

In Reply.

Oncologist 2018 12 17;23(12):e165-e166. Epub 2018 Aug 17.

Cardiology Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1634/theoncologist.2018-0101DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6292538PMC
December 2018

Risk-Imaging Mismatch: Why Is There a Disconnect?

J Clin Oncol 2018 10 31;36(30):2975-2977. Epub 2018 Aug 31.

Chau T. Dang, Anthony F. Yu, Jennifer Liu, and Richard Steingart, Memorial Sloan Kettering Cancer Center, New York, New York.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2018.78.9354DOI Listing
October 2018

Double-Blind Phase III Trial of Adjuvant Chemotherapy With and Without Bevacizumab in Patients With Lymph Node-Positive and High-Risk Lymph Node-Negative Breast Cancer (E5103).

J Clin Oncol 2018 09 24;36(25):2621-2629. Epub 2018 Jul 24.

Kathy D. Miller, Indiana University Melvin and Bren Simon Cancer Center, Indianapolis, IN; Anne O'Neill, Dana-Farber Cancer Institute, Boston, MA; William Gradishar, Northwestern University, Chicago; Nguyet Anh Le-Lindqwister, Heartland Cancer Research National Cancer Institute Community Oncology Research Program, Peoria, IL; Timothy J. Hobday, Mayo Clinic, Rochester; Stuart Bloom, Abbott Northwestern Hospital, Minneapolis, MN; Lori J. Goldstein, Fox Chase Cancer Center, Philadelphia; Adam M. Brufsky, University of Pittsburgh, Pittsburgh, PA; Ingrid A. Mayer, Vanderbilt University, Nashville, TN; Amye J. Tevaarwerk, University of Wisconsin, Madison, WI; Joseph A. Sparano, Montefiore Hospital and Medical Center, Bronx; Chau T. Dang, Memorial Sloan Kettering Cancer Center, New York, NY; Carolyn B. Hendricks, Association Community Clinical Oncology Program, Bethesda, MD; Donald W. Northfelt, Mayo Clinic, Scottsdale, AZ; and George W. Sledge JR, Stanford University, Stanford, CA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2018.79.2028DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6118403PMC
September 2018

Efficacy of Exercise Therapy on Cardiorespiratory Fitness in Patients With Cancer: A Systematic Review and Meta-Analysis.

J Clin Oncol 2018 08 12;36(22):2297-2305. Epub 2018 Jun 12.

Jessica M. Scott, Emily C. Zabor, Scott C. Adams, Chaya S. Moskowitz, Konstantina Matsoukas, Neil M. Iyengar, Chau T. Dang, Lee W. Jones, Memorial Sloan Kettering Cancer Center; Graeme J. Koelwyn, New York University Langone Medical Center; and Chaya S. Moskowitz, Neil M. Iyengar, Chau T. Dang, Lee W. Jones, Weill Cornell Medical College, New York, NY; Emily Schwitzer, Duke University Medical Center, Durham, NC; and Tormod S. Nilsen, The Norwegian School of Sport Sciences, Oslo, Norway.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2017.77.5809DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6804903PMC
August 2018

Left Ventricular Ejection Fraction Monitoring Adherence Rates: Why So Low?

JACC Cardiovasc Imaging 2018 08;11(8):1094-1097

Division of Medical Oncology, Department of Medicine, Ottawa Hospital Cancer Centre, University of Ottawa, Ottawa, Ontario, Canada.

View Article

Download full-text PDF

Source
https://linkinghub.elsevier.com/retrieve/pii/S1936878X183052
Publisher Site
http://dx.doi.org/10.1016/j.jcmg.2018.02.027DOI Listing
August 2018

Cardiac safety of non-anthracycline trastuzumab-based therapy for HER2-positive breast cancer.

Breast Cancer Res Treat 2017 Nov 14;166(1):241-247. Epub 2017 Jul 14.

Department of Medicine, Breast Medicine Service, Memorial Sloan Kettering Cancer Center, Brooklyn, NY, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s10549-017-4362-xDOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5647229PMC
November 2017

Anthracyclines in Early Breast Cancer: The ABC Trials-USOR 06-090, NSABP B-46-I/USOR 07132, and NSABP B-49 (NRG Oncology).

J Clin Oncol 2017 Aug 11;35(23):2647-2655. Epub 2017 Apr 11.

Joanne L. Blum, Lina Asmar, Nicholas J. Robert, Joyce A. O'Shaughnessy, Svetislava J. Vukelja, Devchand Paul, and Stephen E. Jones, US Oncology Research; Lina Asmar, McKesson Specialty Health, The Woodlands; Joanne L. Blum and Joyce A. O'Shaughnessy, Texas Oncology-Baylor Charles A. Sammons Cancer Center, Baylor University Medical Center, Dallas; Svetislava J. Vukelja, Texas Oncology-Tyler, Tyler, TX; Patrick J. Flynn, Charles E. Geyer Jr, Samuel A. Jacobs, Judith O. Hopkins, Louis Fehrenbacher, Alan P. Lyss, Adam M. Brufsky, Sandra M. Swain, Eleftherios P. Mamounas, and Norman Wolmark, National Surgical Adjuvant Breast and Bowel Project/NRG Oncology; Greg Yothers, Jong-Hyeon Jeong, and Linda H. Colangelo, NRG Oncology; Greg Yothers, John-Hyeon Jeong, and Linda H. Colangelo, The University of Pittsburgh; Samuel A. Jacobs, University of Pittsburgh Cancer Institute, University of Pittsburgh School of Medicine; Adam M. Brufsky, Magee-Womens Hospital at University of Pittsburgh Medical Center; Norman Wolmark, Allegheny Cancer Center at Allegheny General Hospital, Pittsburgh; Henry Leonidas Gómez, Eastern Cooperative Oncology Group-American College of Radiology Imaging Network, Philadelphia, PA; Patrick J. Flynn, Metro-Minnesota Community Oncology Research Consortium, Minneapolis, MN; Charles E. Geyer Jr, Massey Cancer Center, Virginia Commonwealth University, Richmond; Nicholas J. Robert, Virginia Cancer Specialists, Fairfax, VA; Judith O. Hopkins, The Southeastern Medical Oncology Center, Goldsboro, NC; Chau T. Dang, The Alliance, Boston, MA; Chau T. Dang, Memorial Sloan Kettering Cancer Center, New York, NY; Henry Leonidas Gómez, Instituto Nacional de Enfermedades Neoplasicas, Lima, Peru; Louis Fehrenbacher, Kaiser Permanente Oncology Clinical Trials Northern California, Vallejo, CA; Alan P. Liss, Heartland Cancer Research National Cancer Institute Community Oncology Research Program at Missouri Baptist Cancer Center, St Louis, MO; Devchand Paul, Rocky Mountain Cancer Centers, Denver, CO; Sandra M. Swain, MedStar Washington Hospital Center Washington Cancer Institute, and Georgetown University Medical Center, Washington, DC; and Eleftherios P. Mamounas, UF Cancer Center at Orlando Health, Orlando, FL.

View Article

Download full-text PDF

Source
http://ascopubs.org/doi/10.1200/JCO.2016.71.4147
Publisher Site
http://dx.doi.org/10.1200/JCO.2016.71.4147DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5549453PMC
August 2017

Breast Cancer Risk in Childhood Cancer Survivors Without a History of Chest Radiotherapy: A Report From the Childhood Cancer Survivor Study.

J Clin Oncol 2016 Mar 23;34(9):910-8. Epub 2015 Dec 23.

Tara O. Henderson and Kenan Onel, University of Chicago, Chicago, IL; Chaya S. Moskowitz, Joanne F. Chou, Chau T. Dang, Danielle Novetsky Friedman, Dana Barnea, Elena Lorenzi, and Kevin C. Oeffinger, Memorial Sloan Kettering Cancer Center, New York, NY; Angela R. Bradbury, University of Pennsylvania, Philadelphia, PA; Joseph Phillip Neglia, University of Minnesota, Minneapolis, MN; Smita Bhatia, University of Alabama, Birmingham, AL; Louise C. Strong and Marilyn Stovall, MD Anderson Cancer Center, Houston, TX; Lisa B. Kenney and Lisa R. Diller, Dana-Farber Cancer Institute/Children's Hospital Boston, Boston, MA; Elena Lorenzi, Humanitas Clinical and Research Center, Rozzano, Milan, Italy; Sue Hammond, Nationwide Children's Hospital, Columbus, OH; Wendy M. Leisenring, Fred Hutchinson Cancer Research Center, Seattle, WA; and Leslie L. Robison and Gregory T. Armstrong, St Jude Children's Research Hospital, Memphis, TN.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2015.62.3314DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4871997PMC
March 2016

Feasibility and cardiac safety of trastuzumab emtansine after anthracycline-based chemotherapy as (neo)adjuvant therapy for human epidermal growth factor receptor 2-positive early-stage breast cancer.

J Clin Oncol 2015 Apr 23;33(10):1136-42. Epub 2015 Feb 23.

Ian E. Krop, Dana-Farber Cancer Institute, Boston, MA; Thomas M. Suter, Bern University Hospital, Bern, Switzerland; Chau T. Dang, Memorial Sloan Kettering Cancer Center, New York; Marc L. Citron, Hofstra North Shore-Long Island Jewish School of Medicine, New Hyde Park, NY; Luc Dirix, Sint-Augustinus Hospital, Antwerp, Belgium; Gilles Romieu, Institut du Cancer de Montpellier Val d'Aurelle, Montpellier; Mario Campone, Institut de Cancérologie de l'Ouest/René Gauducheau, Nantes Saint-Herblain, France; Claudio Zamagni, Policlinico Sant'Orsola-Malpighi Hospital, Bologna; Luca Gianni, San Raffaele Hospital, Milan, Italy; and Na Xu and Melanie Smitt, Genentech, South San Francisco, CA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2014.58.7782DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5657012PMC
April 2015

Trastuzumab interruption and treatment-induced cardiotoxicity in early HER2-positive breast cancer.

Breast Cancer Res Treat 2015 Jan 1;149(2):489-95. Epub 2015 Jan 1.

Department of Medicine, Memorial Sloan Kettering Cancer Center, 1275 York Avenue, New York, NY, 10021, USA,

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s10549-014-3253-7DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4970316PMC
January 2015

Adjuvant paclitaxel and trastuzumab for node-negative, HER2-positive breast cancer.

N Engl J Med 2015 Jan;372(2):134-41

From the Departments of Medical Oncology (S.M.T., B.A.O., A.H.P., I.E.K., H.J.B., E.P.W.) and Biostatistics and Computation Biology (W.T.B., H.G.), Dana-Farber Cancer Institute, and Department of Hematology-Oncology, Massachusetts General Hospital (B.M.) - both in Boston; Breast Cancer Medicine Service, Department of Medicine, Solid Tumor Division, Memorial Sloan Kettering Cancer Center, and Department of Medicine, Weill Cornell Medical Center, New York (C.T.D., C.A.H.), and Department of Medical Oncology, Hofstra North Shore-LIJ School of Medicine, New Hyde Park (I.S.) - all in New York; Sarah Cannon Cancer Center, Department of Medical Oncology, Nashville (D.A.Y.); Department of Medicine, Division of Medical Oncology, Duke Cancer Institute, Durham (P.K.M.), and Department of Medical Oncology, University of North Carolina, Chapel Hill (L.A.C.) - both in North Carolina; Cardinal Bernardin Cancer Center, Department of Medicine, Division of Hematology-Oncology, Loyola University Chicago Stritch School of Medicine, Maywood, IL (K.S.A.); Comprehensive Cancer Center, Department of Medicine, Division of Oncology, University of California, San Francisco, San Francisco (H.S.R.); Department of Medical Oncology, Washington University in St. Louis, St. Louis (M.E.); and Johns Hopkins Kimmel Cancer Center, Department of Oncology, Baltimore (A.C.W.).

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1056/NEJMoa1406281DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4313867PMC
January 2015

Risk of rash with the anti-HER2 dimerization antibody pertuzumab: a meta-analysis.

Breast Cancer Res Treat 2012 Sep 11;135(2):347-54. Epub 2012 Jul 11.

Division of Dermatology, Department of Medicine, University of Toronto, 2075 Bayview Avenue, Toronto, ON M4N 3M5, Canada.

View Article

Download full-text PDF

Source
http://link.springer.com/10.1007/s10549-012-2157-7
Publisher Site
http://dx.doi.org/10.1007/s10549-012-2157-7DOI Listing
September 2012

Anthracyclines are a critical component of adjuvant chemotherapy regimens for high-risk early breast cancer.

Oncology (Williston Park) 2011 Feb;25(2):134-5, 138, 140

Memorial Sloan-Kettering Cancer Center, New York, New York, USA.

View Article

Download full-text PDF

Source
February 2011

Drug treatments for adjuvant chemotherapy in breast cancer: recent trials and future directions.

Authors:
Chau T Dang

Expert Rev Anticancer Ther 2006 Mar;6(3):427-36

Solid Tumor Division, Department of Medicine, Memorial Sloan-Kettering Cancer Center, New York, NY 10021, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1586/14737140.6.3.427DOI Listing
March 2006

The risk of central nervous system metastases after trastuzumab therapy in patients with breast carcinoma.

Cancer 2004 Aug;101(4):810-6

Department of Epidemiology and Biostatistics, McMaster University/Hamilton Regional Cancer Center, Hamilton, Ontario, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/cncr.20418DOI Listing
August 2004

Risk models for neutropenia in patients with breast cancer.

Oncology (Williston Park) 2003 Nov;17(11 Suppl 11):14-20

Breast Cancer Medical Service, Memorial Sloan-Kettering, Cancer Center, New York, New York, USA.

View Article

Download full-text PDF

Source
November 2003

Potential role of selective COX-2 inhibitors in cancer management.

Oncology (Williston Park) 2002 May;16(5 Suppl 4):30-6

Department of Medicine, Memorial Sloan-Kettering Cancer Center, New York, New York 10021, USA.

View Article

Download full-text PDF

Source
May 2002